CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT03854994 · UNKNOWN
Trial details
- NCT number
- NCT03854994
- Sponsor
- Yan'an Affiliated Hospital of Kunming Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2021-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.